Coffee consumption and immune health

Recent scientific reviews continue to examine how coffee influences the immune system and the risk of autoimmune diseases. Both snapshots note that caffeine modulates inflammation by blocking adenosine receptors, affecting T‑cells, cytokine production and macrophage activity. Moderate coffee intake is described as having anti‑inflammatory properties, while excessive consumption may produce variable effects depending on genetics and individual health status.

The analyses also emphasize coffee’s broader phytochemical profile—chlorogenic acids, polyphenols, diterpenes and antioxidants—which can lower oxidative stress and further influence inflammatory pathways. Earlier epidemiological links between high coffee consumption and rheumatoid arthritis have not been confirmed by newer studies; moderate consumption is not shown to increase the risk of rheumatoid arthritis, systemic lupus erythematosus or other autoimmune conditions. One snapshot adds practical guidance, suggesting an optimal drinking window in the mid‑to‑late morning (60–90 minutes after waking) and citing EFSA limits of up to 400 mg caffeine per day for adults.

Overall, the evolving literature portrays coffee as a complex dietary factor with potential immune‑modulating benefits at moderate levels, while the relationship to autoimmune disease risk remains inconclusive and likely shaped by genetic and environmental factors.